Arrow Greentech H1 FY27 Revenue Jumps 69% YoY

Revenue from Operations: ₹1,733 million, representing 68.8% year-over-year growth from ₹1,027 million in H1 FY26
EBITDA: ₹692 million with margin of 40.0%, showing 97.8% YoY growth from ₹350 million (586 basis points margin improvement from 34.1%)
Profit After Tax: ₹525 million with PAT margin of 29.5%, representing 97.1% YoY growth from ₹267 million (451 basis points margin improvement from 25.0%)
EPS: ₹34.81 for H1 FY27 compared to ₹17.66 in H1 FY26

Revenue from Operations: ₹855 million, representing 39.9% YoY growth from ₹611 million in Q2 FY26
EBITDA: ₹333 million with margin of 39.0%, showing 60.5% YoY growth from ₹208 million
Profit After Tax: ₹251 million with PAT margin of 28.7%, representing 59.5% YoY growth from ₹157 million
EPS: ₹16.66 for Q2 FY27

High-Tech Product segment revenue grew to ₹1,563 million in H1 FY27, representing 87.8% YoY growth from ₹832 million
Green Products segment showed consistent order flow and on-time delivery performance

Company granted four new patents during H1 FY27 (three in India, one in Singapore)
Total of 23 granted patents globally across territories including India, UK, USA, Europe, Singapore, Sri Lanka, and Malaysia
41 registered trademarks in India with 26 additional trademark applications under processing
State-of-the-art manufacturing facilities located in Ankleshwar, Gujarat with provision for future expansion
Presence in Europe, Asia, North & South America, and Africa with three supply points

Arrow Greentech develops, produces, and markets water-soluble films with applications across multiple industries:

Packaging: Unit-dose packaging for detergents, cleaning agents, agrochemicals
Healthcare: PVOH-based bags for contaminated linen handling in hospitals
Agriculture: Monodosing and packaging for pesticides and crop protection products
Textiles: Water-soluble backing for embroidery
Consumer Goods: Pouches for laundry detergents and household cleaning products

100% wholly-owned subsidiary focused on Mouth Dissolving Strips (MDS) technology
Patented Embedded Water-Soluble Film platform for oral drug administration
Multiple delivery routes: lingual, sublingual, and buccal
Applications in pediatric, geriatric, psychiatric, and veterinary therapies

Watersol Capsules: Hygiene products in water-soluble capsules
BioPlast: Bio-compostable film as eco-friendly alternative to single-use plastic
Extensive list of FSSAI-approved nutraceutical products (40 products listed)
RX approved products including Nicotine Polacrilex, Ondansetron, Sildenafil, Amlodipine, and others

Board of Directors includes:

Mr. Shilpan P. Patel (Chairman & Managing Director) - Oversees Business Development and Strategic Management
Mr. Neil Patel (Joint Managing Director) - Member of Audit and Stakeholders Relationship committee
Mr. Prashant Mehta (Independent Director) - Expertise in legal and secretarial affairs
Mrs. Jigisha Patel (Non-Executive Non-Independent Woman Director) - Administration and corporate affairs
Mr. Yogesh Gajjar (Independent Director) - Electronics and electrical services expertise
Mrs. Barkharani Nevatia (Independent Director) - Chartered Accountant with corporate tax and audit expertise

Total Assets: ₹3,096 million (compared to ₹2,558 million in March 2026)
Current Assets: ₹2,597 million (including Investments: ₹1,291 million, Cash & Cash Equivalents: ₹374 million)
Total Equity: ₹2,818 million (Equity Share Capital: ₹151 million, Other Equity: ₹2,649 million)
Current Liabilities: ₹260 million (including Current tax liabilities: ₹100 million)

Water-soluble films market expected to reach $586 million by 2029 at CAGR of 5.8%
North America projected as largest market
Market valued at USD 442 million in 2024
PVA (Polyvinyl Alcohol) as key material due to water solubility and film-forming properties
Driven by environmental regulations, plastic waste reduction policies, and sustainability initiatives